For example, obeticholic acid, a potent FXR agonist is currently used to treat PBC and has also shown many beneficial effects in the treatment of NAFLD/NASH and PSC (192, 193). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.